Osaic Holdings’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.12K | Buy |
610
+600
| +6,000% | +$7.99K | ﹤0.01% | 5882 |
|
2025
Q1 | $59 | Sell |
10
-600
| -98% | -$3.54K | ﹤0.01% | 7091 |
|
2024
Q4 | $8.12K | Sell |
610
-34
| -5% | -$453 | ﹤0.01% | 5839 |
|
2024
Q3 | $5.24K | Buy |
+644
| New | +$5.24K | ﹤0.01% | 6058 |
|
2024
Q2 | – | Sell |
-669
| Closed | -$11.6K | – | 7182 |
|
2024
Q1 | $11.6K | Buy |
669
+580
| +652% | +$10K | ﹤0.01% | 5612 |
|
2023
Q4 | $1.15K | Sell |
89
-88
| -50% | -$1.13K | ﹤0.01% | 6562 |
|
2023
Q3 | $6.55K | Buy |
177
+4
| +2% | +$148 | ﹤0.01% | 6088 |
|
2023
Q2 | $6.95K | Sell |
173
-11
| -6% | -$442 | ﹤0.01% | 6105 |
|
2023
Q1 | $13.3K | Sell |
184
-2
| -1% | -$145 | ﹤0.01% | 5783 |
|
2022
Q4 | $15.8K | Buy |
186
+152
| +447% | +$12.9K | ﹤0.01% | 5713 |
|
2022
Q3 | $3K | Sell |
34
-1
| -3% | -$88 | ﹤0.01% | 6519 |
|
2022
Q2 | $7K | Buy |
35
+5
| +17% | +$1K | ﹤0.01% | 6260 |
|
2022
Q1 | $7K | Sell |
30
-5
| -14% | -$1.17K | ﹤0.01% | 6261 |
|
2021
Q4 | $14K | Buy |
35
+9
| +35% | +$3.6K | ﹤0.01% | 5995 |
|
2021
Q3 | $11K | Sell |
26
-26
| -50% | -$11K | ﹤0.01% | 6113 |
|
2021
Q2 | $21K | Sell |
52
-3
| -5% | -$1.21K | ﹤0.01% | 5607 |
|
2021
Q1 | $19K | Sell |
55
-1,173
| -96% | -$405K | ﹤0.01% | 5475 |
|
2020
Q4 | $602K | Buy |
1,228
+184
| +18% | +$90.2K | ﹤0.01% | 2472 |
|
2020
Q3 | $338K | Buy |
1,044
+1,030
| +7,357% | +$333K | ﹤0.01% | 2780 |
|
2020
Q2 | $4K | Sell |
14
-23
| -62% | -$6.57K | ﹤0.01% | 5481 |
|
2020
Q1 | $8K | Buy |
+37
| New | +$8K | ﹤0.01% | 5062 |
|